shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Jun 14th - DDP 2021 International Conference [The George Hull Centre Institute for Childhood Trauma & Attachment and DDPI]
Jun 14th - EMDR Unchained: Going from Protocol to Treatment [Leading Edge Seminars]
Jun 14th - Helping families heal: Addressing and treating trauma in children, youth and families [SickKids CCMH Learning Institute]
Jun 15th - Happiness in Dark Times: The Role of Positivity in Catalyzing Resilience [Leading Edge Seminars]
Jun 17th - New Hope for Treatment-Resistant Depression [Leading Edge Seminars]
schools agencies and other institutional orders (click here)
Due to the current Covid-19 situation, we are open only for pickups 9-6 Mon-Sat and 12-5 Sunday. Free shipping across Canada for orders over $75. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Deprescribing in Psychiatry
Gupta, Swapnil, Rebecca Miller and John Cahill
Oxford University Press / Softcover / 2019-10-01 / 0190654813
Psychopharmacology / Psychiatry
price: $54.95 (may be subject to change)
224 pages
Not in Stock, usually ships in 7-10 business days

The current state of medicine has witnessed the long-term adverse effects of certain medications, an increased rate of polypharmacy, and a cultural shift that emphasizes patient-centered practice. The term "deprescribing" refers to the optimization of the pharmacological regimen by reducing or cessing medications that incur more risks than benefits.

Many people consider stopping their psychiatric medications, but prescribers may not know how to do this in a collaborative, systematic way. Deprescribing in Psychiatry presents a framework for deprescribing to guide the prescriber-patient dyad through the process of deciding if and when to reduce psychiatric medication, how to go about doing it, and at the same time, acknowledge the inherent risks in such an endeavour.

As the first book on the subject, Deprescribing in Psychiatry stands to serve as a definitive text in this burgeoning field and as a 'rallying call' to raise crucial and topical questions in psychiatric practice, promote innovation, and act as a resource on the current state-of-the-art care. It describes the ins and outs of how clinicians can work closely with their patients to consider whether or not to try decreasing medications. It also discusses the anticipated future research directions, considerations for the field, and emphasizes collaboration with the patient, transparency, and the acknowledgement of uncertainty in psychiatric practice.

About the Authors:

Swapnil Gupta, MBBS, MD is an Assistant Professor in the Department of Psychiatry at Yale University School of Medicine.

Rebecca Miller, PhD is an Assistant Professor in the Department of Psychiatry at Yale University School of Medicine.

John D. Cahill, BMBS, PhD is an Assistant Professor in the Department of Psychiatry at Yale University School of Medicine.

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / 12-5 Sun (EST)

search
Click here to read previous issues.
other lists
Oxford University Press
Psychiatry
Psychopharmacology
Spring 2020 Catalogue Titles